نتایج جستجو برای: dpd

تعداد نتایج: 1316  

Journal: :Anticancer research 2005
Toshio Shimizu Yasuhide Yamada Hisateru Yasui Kuniaki Shirao Masahiro Fukuoka

BACKGROUND A highly specific antibody against recombinant human dihydropyrimidine dehydrogenase (DPD) has been developed to immunohistochemically assess DPD expression in tumors. A new oral DPD inhibitory fluoropyrimidine (DIF), S-1, is reportedly effective against gastric scirrhous carcinoma. PATIENTS AND METHODS In this study, the relationship between immunoreactivity to DPD in biopsy speci...

2001
W. Vesper S. Jay Smith Cynthia Audain

Measurement of biochemical bone markers is commonly used in the management of various metabolic bone diseases (1, 2). The pyridinium crosslinks pyridinoline (PYD) and deoxypyridinoline (DPD) are well-characterized markers for bone resorption that have been available for several years (3 ). Assays to measure the sum of free and peptide-bound urinary PYD or DPD (total PYD or DPD) or free, non-pep...

Journal: :medical journal of islamic republic of iran 0
alireza ahmadvand department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences) farshad farzadfar non-communicable diseases research center, endocrinology and metabolism population science institute, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)سازمان های دیگر: non-communicable diseases research center endocrinology and metabolism population science institute, hamid reza jamshidi department of pharmacology, faculty of medicine, shahidbeheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) naser mohammadi research and development manager, barakat pharmed pharmaceutical investment corporation, tehran, iran.سازمان های دیگر: barakat pharmed pharmaceutical investment corporation, kourosh holakouie-naieni department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

background: statins have been effective medications in lowering serum total cholesterol (tc) concentrations across populations over time. the aim of this study was to estimate national and provincial trends in atorvastatin sales in iran, to systematically quantify its relationship with socio-economic indicators, and changes in tc level.   methods : in this retrospective ecological study, conduc...

ژورنال: :پژوهش های کاربردی در شیمی 0
کیومرث زرگوش استادیار شیمی تجزیه، دانشکده شیمی، دانشگاه صنعتی اصفهان، اصفهان، ایران محمدرسول سهرابی دانشجوی کارشناسی ارشد شیمی تجزیه، دانشکده شیمی، دانشگاه صنعتی اصفهان، اصفهان، ایران امیر عبدالملکی دانشیار شیمی آلی، دانشکده شیمی، دانشگاه صنعتی اصفهان، اصفهان، ایران کوروش فیروز دانشجوی دکتری شیمی آلی، دانشکده شیمی، دانشگاه صنعتی اصفهان، اصفهان، ایران

ترکیب جدید (n2,n6-di(thiazol-2-yl)pyridine-2,6-dicarboxamide(dpd 2-نیتروژن، 6-نیتروژن دی (تیازول-2-ایل) پیریدین-2 و 6-دی کربوکسیلامید با استفاده از واکنش بین 2-آمینوتی ازول و پیریدین دی کربوکسیلیک اسید سنتز شد. ساختار dpd با تجزیه عنصری، طیف سنجی فروسرخ (ft-ir) و رزونانس مغناطیسی هسته (1hnmr) بررسی و تأیید شد. قابلیت حذف یون های فلزات سنگین (cd2+ و zn2+) از محلول، با dpd مورد مطالعه قرار گرفت. ...

ترکیب جدید (N2,N6-di(thiazol-2-yl)pyridine-2,6-dicarboxamide(DPD 2-نیتروژن، 6-نیتروژن دی (تیازول-2-ایل) پیریدین-2 و 6-دی کربوکسیلامید با استفاده از واکنش بین 2-آمینوتی ازول و پیریدین دی‌کربوکسیلیک اسید سنتز شد. ساختار DPD با تجزیه عنصری، طیف‌سنجی فروسرخ (FT-IR) و رزونانس مغناطیسی هسته (1HNMR) بررسی و تأیید شد. قابلیت حذف یون‌های فلزات سنگین (Cd2+ و Zn2+) از محلول، با DPD مورد مطالعه قرار گرفت. ...

Journal: :Anticancer research 2005
Yoshifumi Nakayama Yuzuru Inoue Nobuo Nagashima Takefumi Katsuki Kentarou Matsumoto Koji Kadowaki Kazunori Shibao Yosuke Tsurudome Keiji Hirata Tatsuhiko Sako Naoki Nagata Hideaki Itoh

BACKGROUND Thymidine phosphorylase (TP) is a key enzyme involved in pyrimidine nucleoside metabolism. Dihydropyrimidine dehydrogenase (DPD) is the major catabolic enzyme of 5-fluorouracil (5-FU). These are important enzymes in the pyrimidine salvage pathway and are considered to be key enzymes for determining the prognosis of patients with gastrointestinal cancer. In the present study, TP and D...

Journal: :British journal of clinical pharmacology 2016
Maurice C van Staveren Andre B P van Kuilenburg Henk-Jan Guchelaar Judith Meijer Cornelis J A Punt Robert S de Jong Hans Gelderblom Jan Gerard Maring

AIM Dihydropyrimidine dehydrogenase (DPD) deficiency can lead to severe toxicity following 5-fluorouracil (5FU) or capecitabine (CAP) treatment. Uracil (U) can be used as a probe to determine systemic DPD activity. The present study was performed to assess the sensitivity and specificity of a U loading dose for detecting DPD deficiency. METHODS Cancer patients with Common Toxicity Score (CTC)...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
Y Ishikawa T Kubota Y Otani M Watanabe T Teramoto K Kumai M Kitajima T Takechi H Okabe M Fukushima

We investigated the correlation between tumor sensitivity to 5-fluorouracil (5-FU) and the enzymatic activity and mRNA levels of thymidylate synthetase (TS) and dihydropyrimidine dehydrogenase (DPD) using human tumor xenografts in nude mice. Three gastric carcinoma xenografts (SC-1-NU, St-4, and H-111), two colon carcinoma xenografts (Co-4 and Col-3-JCK), one pancreatic carcinoma xenograft (PAN...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
R B Diasio M R Johnson

DPD (also known as dihydrouracil dehydrogenase, dihydrothymine dehydrogenase, and uracil reductase; EC 1.3.1.2) is the initial enzyme and the rate-limiting step in the pyrimidine catabolic pathway (1). Studies over the past two decades have demonstrated that DPD is an important regulatory enzyme in the metabolism of both the naturally occurring pyrimidines uracil and thymine as well as the canc...

Journal: :The Biochemical journal 2002
André B P van Kuilenburg Doreen Dobritzsch Rutger Meinsma Janet Haasjes Hans R Waterham Malgorzata J M Nowaczyk George D Maropoulos Guido Hein Hermann Kalhoff Jean M Kirk Holger Baaske Anne Aukett John A Duley Kate P Ward Ylva Lindqvist Albert H van Gennip

Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterized by thymine-uraciluria in homozygous deficient patients. Cancer patients with a partial deficiency of DPD are at risk of developing severe life-threatening toxicities after the administration of 5-fluorouracil. Thus, identification of novel disease-causing mutations is of the utmost importance to all...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید